Table 2. Influence of the ketogenic diet on metastatic tumor growth and circulating energy metabolites in a patient with non-small-cell lung cancer.
C-CT: chest computed tomography; B-CT: brain computed tomography; B-MRI: brain magnetic resonance imaging; Glu: fasting glucose levels (mg/dL); KB: ketones in blood (mmol/L); Cho: cholesterol (mg/dL), HDL-cho: high-density lipoprotein cholesterol (mg/dL); LDL-cho: low-density lipoprotein cholesterol (mg/dL); Tri: triglycerides (mg/dL); W: patient’s weight; DCI: daily calorie intake; KDR: ketogenic diet ratio represented as fats:carbohydrates + protein
| Date | C-CT (cm) | B-CT (cm) | B-MRI | Glu | KB | Cho | HDL-cho | LDL-cho | Tri | W | DCI | KDR |
| 08.07.08 | 2 × 1.7 | 86–90 | 0.6 | 220 | 40 | 120 | 170 | 76 | 2,275 | 1:1 | ||
| 12.09.08 | 2 × 1.6 | 61–71 | 0.9 | 180 | 50 | 100 | 150 | 2,293 | 2:1 | |||
| 26.09.08 | 3.1 × 2 | 86–90 | 0.8 | 2,293 | 3:1 | |||||||
| 05.03.09 | 1.7 × 1.5 | 2 × 1.5 | 71–73 | 1.5 | 2,000 | 3:1 | ||||||
| 03.06.09 | 1.7 × 1.5 | 2 × 1.5 | 65 | 2.1 | 1,700 | 3:1 | ||||||
| 07.10.09 | 1.7 × 1 | 1.9 × 1 | 71 | 2.1 | 1,700 | 3:1 | ||||||
| 31.05.10 | 1.7 × 0.8 | 1.8 × 1 | 75 | 2.0 | 180 | 55 | 100 | 160 | 2,200 | 3:1 | ||
| 15.10.10 | 1.8 × 1 | 65 | 2.0 | 2,200 | 3:1 | |||||||
| 07.01.11 | 1.7 × 0.8 | 1.8 × 1 | 70 | 1.9 | 2,100 | 3:1 | ||||||
| 06.10.11 | 1.8 × 1 | 60 | 2.1 | 2,000 | 3:1 | |||||||
| 15.02.12 | 1.7 × 0.8 | 1.8 × 1 | 70 | 2.1 | 2,100 | 3:1 | ||||||
| 13.06.18 | 1.7 × 0.8 | 70 | 2.1 | |||||||||
| 08.07.18 | 1.7 × 0.8 | 70 | 2.0 | 280 | 45 | 140 | 300 | 2,100 | 3:1 |